| Sarah Landherr, COTA | |
|
14505 W Granite Valley Dr., Sun City West, AZ 85375 | |
| (623) 975-8000 | |
| (480) 242-5903 |
| Full Name | Sarah Landherr |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy Assistant |
| Location | 14505 W Granite Valley Dr., Sun City West, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316456510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 6996 (Arizona) | Secondary |
| 224Z00000X | Occupational Therapy Assistant | 6996 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Landherr, COTA 805 W Rockwood Dr., Phoenix, AZ 85027 Ph: (480) 242-5903 | Sarah Landherr, COTA 14505 W Granite Valley Dr., Sun City West, AZ 85375 Ph: (623) 975-8000 |
News Archive
Starpharma Holdings Ltd (ASX:SPL; OTCQX: SPHRY) is pleased to report that recruitment is now 100% complete for its Phase 2 clinical trial to investigate the ability of VivaGel® to prevent the recurrence of BV, and also for the first of two pivotal Phase 3 studies of VivaGel® for the treatment of BV.
The human placenta is an organ unlike any other. During the course of nine months it is formed by the embryo, sustains life and then is shed.
After 20 years of dedicated research, scientists have cracked the chemical code of an incredibly complex 'anti-tumor antibiotic' known to be highly effective against cancer cells as well as drug-resistant bacteria, and have reproduced it synthetically in the lab for the first time.
The initial study results of the Zometa European Study (ZEUS) showed no difference in the incidence of bone metastases between the Zometa group and control arm, said Prof. Manfred Wirth during the closing and fourth plenary session of the 28th Annual EAU Congress which ends today.
› Verified 6 days ago